After Maggi, Patanjali Atta Noodles found ‘sub-standard’

  • News
  • April 15, 2016

Meerut

A team of Food Safety and Drugs Administration (FSDA) based in Meerut has found a Patanjali Atta Noodles sample “sub-standard”, with ash content in the taste maker exceeding the prescribed limits by nearly three times, even higher than Maggi samples. The tests were carried out on samples of Patanjali Noodles, Maggi and Yippee collected from Meerut on February 5, 2016, the report of which reached came out on Saturday. In all the three samples, ash content found is invariably high.The permissible limit for ash content according to law is 1%, but all the three samples failed the test and were found “substandard” for consumption.

  • Related Posts

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Rajasthan Drops 1,114 Hospitals From RGHS in Fraud Drive

    Jaipur, August 18, 2025 — Rajasthan has removed 1,114 private hospitals from the Rajasthan Government Health Scheme (RGHS) after a statewide fraud sweep. The Health Department also suspended 1,901 healthcare…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework